| 1 |
Yu L, Yu M, Chen W, Sun S, Huang W, Wang T, Peng Z, Luo Z, Fang Y, Li Y, Deng Y, Wu M, Tao W. In Situ Separable Nanovaccines with Stealthy Bioadhesive Capability for Durable Cancer Immunotherapy. J Am Chem Soc 2023. [PMID: 36930579 DOI: 10.1021/jacs.2c12986] [Reference Citation Analysis]
|
| 2 |
Chang J, Yu B, Saltzman WM, Girardi M. Nanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment. JID Innovations 2023. [DOI: 10.1016/j.xjidi.2023.100197] [Reference Citation Analysis]
|
| 3 |
Wang Y, Malik S, Suh HW, Xiao Y, Deng Y, Fan R, Huttner A, Bindra RS, Singh V, Saltzman WM, Bahal R. Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Sci Adv 2023;9:eabq7459. [PMID: 36753549 DOI: 10.1126/sciadv.abq7459] [Reference Citation Analysis]
|
| 4 |
Farhana A. Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects. Int J Mol Sci 2023;24. [PMID: 36834917 DOI: 10.3390/ijms24043493] [Reference Citation Analysis]
|
| 5 |
Abdellatif AAH, Aldosari BN, Al-Subaiyel A, Alhaddad A, Samman WA, Eleraky NE, Elnaggar MG, Barakat H, Tawfeek HM. Transethosomal Gel for the Topical Delivery of Celecoxib: Formulation and Estimation of Skin Cancer Progression. Pharmaceutics 2022;15. [PMID: 36678651 DOI: 10.3390/pharmaceutics15010022] [Reference Citation Analysis]
|
| 6 |
Mai Y, Ouyang Y, Yu M, Qin Y, Girardi M, Saltzman WM, Cocco E, Zhao C, Yu L, Jia Y, Xiao L, Dou L, Deng W, Liu Y, Xie J, Deng Y. Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis. J Control Release 2022;349:354-66. [PMID: 35817278 DOI: 10.1016/j.jconrel.2022.07.006] [Reference Citation Analysis]
|
| 7 |
Shin K, Suh HW, Grundler J, Lynn AY, Pothupitiya JU, Moscato ZM, Reschke M, Bracaglia LG, Piotrowski-Daspit AS, Saltzman WM. Polyglycerol and Poly(ethylene glycol) exhibit different effects on pharmacokinetics and antibody generation when grafted to nanoparticle surfaces. Biomaterials 2022;287:121676. [PMID: 35849999 DOI: 10.1016/j.biomaterials.2022.121676] [Reference Citation Analysis]
|
| 8 |
Mai Y, Ouyang Y, Qin Y, Jia C, McCoubrey LE, Basit AW, Nie Y, Jia Y, Yu L, Dou L, Deng W, Deng Y, Liu Y. Poly(lactic acid)-hyperbranched polyglycerol nanoparticles enhance bioadhesive treatment of esophageal disease and reduce systemic drug exposure. Nanoscale 2022. [PMID: 35639565 DOI: 10.1039/d2nr01846b] [Reference Citation Analysis]
|
| 9 |
Yu L, Luo Z, Chen T, Ouyang Y, Xiao L, Liang S, Peng Z, Liu Y, Deng Y. Bioadhesive Nanoparticles for Local Drug Delivery. Int J Mol Sci 2022;23:2370. [PMID: 35216484 DOI: 10.3390/ijms23042370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Sharma N, Bietar K, Stochaj U. Targeting nanoparticles to malignant tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Wang Y, Malik S, Suh H, Xiao Y, Deng Y, Fan R, Huttner A, Bindra RS, Saltzman WM, Bahal R. Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy.. [DOI: 10.1101/2022.01.31.478549] [Reference Citation Analysis]
|
| 12 |
Lu L, Wang K, Lin C, Yang W, Duan Q, Li K, Cai K. Constructing nanocomplexes by multicomponent self-assembly for curing orthotopic glioblastoma with synergistic chemo-photothermal therapy. Biomaterials 2021;279:121193. [PMID: 34700227 DOI: 10.1016/j.biomaterials.2021.121193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Duan W, Bian X, Bu Y. Applications of Bioadhesives: A Mini Review. Front Bioeng Biotechnol 2021;9:716035. [PMID: 34540814 DOI: 10.3389/fbioe.2021.716035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
